Therapeutic effects of different regimens for induction therapy in elderly patients more than 50 years old with newly diagnosed acute myeloid leukaemia
Author(s) -
Junmei Liu,
Liang Zhong,
Yao Juanjuan,
Pengqiang Zhong,
Zhen Yuan,
Dongdong Liu,
Lianwen Li,
Lu Liu,
Yi Zhao,
Shifei Yao,
Min Chen,
Beizhong Liu
Publication year - 2018
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.254
H-Index - 30
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2018.12.21
Subject(s) - medicine , cytarabine , aclarubicin , idarubicin , regimen , gastroenterology , decitabine , incidence (geometry) , adverse effect , daunorubicin , surgery , myeloid leukemia , chemotherapy , gene expression , physics , dna methylation , gene , chemistry , optics , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom